Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells

Marta Truffi(Istituti Clinici Scientifici Maugeri), Davide Prosperi(University of Milano-Bicocca)
Scientific Reports
April 20, 2018
Cited by 73


Related Papers